Table 1.
BMD and osteocalcin in control group and PMO pre and post therapy
| S.no. | Bone mineral density and serum intact osteocalcin | Postmenopausal non osteoporosis women | Postmenopausal osteoporosis women | |
|---|---|---|---|---|
| Controls, n = 60 | Baseline, n = 60 | Post therapy, n = 60 | ||
| Mean ± SD | Mean ± SD | Mean ± SD | ||
| 1 | T-score | 0.345 ± 0.731 | −3.233 ± 0. 752* | −2.083 ± 0.770* |
| Z-score | 0.366 ± 0.698 | −2.735 ± 1.539* | −1.713 ± 0.417* | |
| 2 | Intact osteocalcin (ng/ml) | 11.467 ± 3.183 | 25.184 ± 4.974* | 14.640 ± 4.475* |
The statistical method used to compare data was Z test and paired t test
* P < 0.001 highly significant